Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
St. Joseph's Hospital (Emory)
mi
from
Atlanta, GA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
St. Joseph's Hospital (Emory)
mi
from
Atlanta, GA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Coliseum Medical Center
mi
from
Macon, GA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Coliseum Medical Center
mi
from
Macon, GA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
University of Chicago Medical Center
mi
from
Chicago, IL
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
University of Illinois at Chicago
mi
from
Chicago, IL
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Jewish Hospital
mi
from
Louisville, KY
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Jewish Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Norton Cardiovascular Associates
mi
from
Louisville, KY
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Norton Cardiovascular Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Minneapolis Heart Institute Foundation/ Abbott Northwestern Hospital
mi
from
Minneapolis, MN
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Minneapolis Heart Institute Foundation/ Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Mayo Clinic Hospital, St. Mary's Campus
mi
from
Rochester, MN
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Mayo Clinic Hospital, St. Mary's Campus
mi
from
Rochester, MN
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
North Mississippi Medical Center
mi
from
Tupelo, MS
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
North Mississippi Medical Center
mi
from
Tupelo, MS
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Saint Lukes Hospital
mi
from
Kansas City, MO
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Saint Lukes Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Gateway Cardiovascular Research Center Inc.
mi
from
St. Louis, MO
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Gateway Cardiovascular Research Center Inc.
mi
from
St. Louis, MO
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
NC Heart and Vascular Research
mi
from
Raleigh, NC
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
NC Heart and Vascular Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Oklahoma Heart
mi
from
Oklahoma City, OK
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Oklahoma Heart
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Providence Cardiology LLC
mi
from
Columbia, SC
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Providence Cardiology LLC
mi
from
Columbia, SC
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Baptist Memorial Hospital
mi
from
Memphis, TN
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Baptist Memorial Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
VA North Texas Health Care System
mi
from
Dallas, TX
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
VA North Texas Health Care System
mi
from
Dallas, TX
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
CHI St. Luke's Health / Baylor St. Luke's Medical Center
mi
from
Houston, TX
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
CHI St. Luke's Health / Baylor St. Luke's Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Houston Methodist Hospital
mi
from
Houston, TX
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
The Heart Hospital Baylor Plano
mi
from
Plano, TX
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
U of TX Health Science Center San Antonio (UTHSCSA)
mi
from
San Antonio, TX
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
U of TX Health Science Center San Antonio (UTHSCSA)
mi
from
San Antonio, TX
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Trinity Mother Frances/Cardiovascular Associates of East Texas PA
mi
from
Tyler, TX
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Trinity Mother Frances/Cardiovascular Associates of East Texas PA
mi
from
Tyler, TX
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Sentara Cardiovascular Research Institute / Norfolk General
mi
from
Norfolk, VA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Sentara Cardiovascular Research Institute / Norfolk General
mi
from
Norfolk, VA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Ochsner Clinic Foundation
mi
from
New Orleans, LA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Mount Sinai Hosp
mi
from
New York, NY
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
York Hospital
mi
from
York, PA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated:  12/15/2015
Heart Center Alfred Hospital
mi
from
Melbourne,
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
AVERT™ Clinical Trial
Status: Enrolling
Updated: 12/15/2015
Heart Center Alfred Hospital
mi
from
Melbourne,
Click here to add this to my saved trials
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated:  12/16/2015
University of Alabama - Division of Nephrology
mi
from
Birmingham, AL
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated: 12/16/2015
University of Alabama - Division of Nephrology
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated:  12/16/2015
University of Iowa - Nephrology Division
mi
from
Iowa City, IA
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated: 12/16/2015
University of Iowa - Nephrology Division
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated:  12/16/2015
University of Minnesota Dept of Surgery - Transplantation Division
mi
from
Minneapolis, MN
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated: 12/16/2015
University of Minnesota Dept of Surgery - Transplantation Division
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated:  12/16/2015
Hennepin County Medical Center - Division of Nephrology
mi
from
Minneapolis, MN
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated: 12/16/2015
Hennepin County Medical Center - Division of Nephrology
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated:  12/16/2015
Mayo Clinic - Division of Nephrology
mi
from
Rochester, MN
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated: 12/16/2015
Mayo Clinic - Division of Nephrology
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated:  12/16/2015
University of Alberta - Division of Nephrology & Immunology
mi
from
Edmonton,
A Study of Factors That Affect Long-Term Kidney Transplant Function
Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)
Status: Enrolling
Updated: 12/16/2015
University of Alberta - Division of Nephrology & Immunology
mi
from
Edmonton,
Click here to add this to my saved trials
WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients
WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients, Sponsor Protocol Dated 8/11/2005 and Investigator Brochure Version August 2005
Status: Enrolling
Updated:  12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients
WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients, Sponsor Protocol Dated 8/11/2005 and Investigator Brochure Version August 2005
Status: Enrolling
Updated: 12/16/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
Status: Enrolling
Updated:  12/17/2015
OPKO Renal
mi
from
Bannockburn, IL
Safety and Efficacy of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
Status: Enrolling
Updated: 12/17/2015
OPKO Renal
mi
from
Bannockburn, IL
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
Investigative Clinical Research of Indiana
mi
from
Indianapolis, IN
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
Investigative Clinical Research of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
University of Maryland
mi
from
Baltimore, MD
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
Weill-Cornell Medical College
mi
from
New York, NY
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
Mount Sinai Hospital
mi
from
New York, NY
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated:  12/18/2015
VA Puget Sound Health Care System
mi
from
Seattle, WA
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
PH Ib Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Status: Enrolling
Updated: 12/18/2015
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Severe Renal Impairment and in Matched Healthy Volunteers
Status: Enrolling
Updated:  12/18/2015
Avail Clinical Research
mi
from
DeLand, FL
PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Severe Renal Impairment and in Matched Healthy Volunteers
Status: Enrolling
Updated: 12/18/2015
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Severe Renal Impairment and in Matched Healthy Volunteers
Status: Enrolling
Updated:  12/18/2015
University of Miami
mi
from
Miami, FL
PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Severe Renal Impairment and in Matched Healthy Volunteers
Status: Enrolling
Updated: 12/18/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
A Phase 1 Open-Label, Parallel-Group, Adaptive, Single Dose Study to Evaluate the Pharmacokinetics of GS-6615 in Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  12/18/2015
Clinical Research Facility
mi
from
DeLand, FL
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
A Phase 1 Open-Label, Parallel-Group, Adaptive, Single Dose Study to Evaluate the Pharmacokinetics of GS-6615 in Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 12/18/2015
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials